These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 22070184)
1. Anticholinergics for overactive bladder therapy: central nervous system effects. Chancellor M; Boone T CNS Neurosci Ther; 2012 Feb; 18(2):167-74. PubMed ID: 22070184 [TBL] [Abstract][Full Text] [Related]
2. Blood-brain barrier permeation and efflux exclusion of anticholinergics used in the treatment of overactive bladder. Chancellor MB; Staskin DR; Kay GG; Sandage BW; Oefelein MG; Tsao JW Drugs Aging; 2012 Apr; 29(4):259-73. PubMed ID: 22390261 [TBL] [Abstract][Full Text] [Related]
3. Central nervous system safety of anticholinergic drugs for the treatment of overactive bladder in the elderly. Scheife R; Takeda M Clin Ther; 2005 Feb; 27(2):144-53. PubMed ID: 15811477 [TBL] [Abstract][Full Text] [Related]
6. Safety and tolerability profiles of anticholinergic agents used for the treatment of overactive bladder. Oefelein MG Drug Saf; 2011 Sep; 34(9):733-54. PubMed ID: 21830836 [TBL] [Abstract][Full Text] [Related]
7. A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder. Callegari E; Malhotra B; Bungay PJ; Webster R; Fenner KS; Kempshall S; LaPerle JL; Michel MC; Kay GG Br J Clin Pharmacol; 2011 Aug; 72(2):235-46. PubMed ID: 21392072 [TBL] [Abstract][Full Text] [Related]
8. [Cognitive adverse effects of anticholinergic medication for overactive bladder in PD/DLB]. Sakakibara R Rinsho Shinkeigaku; 2013; 53(11):1389-92. PubMed ID: 24292000 [TBL] [Abstract][Full Text] [Related]
9. Cognitive Effects of Anticholinergic Load in Women with Overactive Bladder. Araklitis G; Robinson D; Cardozo L Clin Interv Aging; 2020; 15():1493-1503. PubMed ID: 32921995 [TBL] [Abstract][Full Text] [Related]
10. Overactive bladder in the elderly: a guide to pharmacological management. Staskin DR Drugs Aging; 2005; 22(12):1013-28. PubMed ID: 16363885 [TBL] [Abstract][Full Text] [Related]
11. Preserving cognitive function for patients with overactive bladder: evidence for a differential effect with darifenacin. Kay GG; Ebinger U Int J Clin Pract; 2008 Nov; 62(11):1792-800. PubMed ID: 18699842 [TBL] [Abstract][Full Text] [Related]
12. Trospium chloride has no effect on memory testing and is assay undetectable in the central nervous system of older patients with overactive bladder. Staskin D; Kay G; Tannenbaum C; Goldman HB; Bhashi K; Ling J; Oefelein MG Int J Clin Pract; 2010 Aug; 64(9):1294-300. PubMed ID: 20561092 [TBL] [Abstract][Full Text] [Related]
13. Antimuscarinic drugs: review of the cognitive impact when used to treat overactive bladder in elderly patients. Pagoria D; O'Connor RC; Guralnick ML Curr Urol Rep; 2011 Oct; 12(5):351-7. PubMed ID: 21607875 [TBL] [Abstract][Full Text] [Related]
14. Antimuscarinic agents: implications and concerns in the management of overactive bladder in the elderly. Kay GG; Granville LJ Clin Ther; 2005 Jan; 27(1):127-38; quiz 139-40. PubMed ID: 15763613 [TBL] [Abstract][Full Text] [Related]
15. Trospium chloride treatment of overactive bladder. Biastre K; Burnakis T Ann Pharmacother; 2009 Feb; 43(2):283-95. PubMed ID: 19193592 [TBL] [Abstract][Full Text] [Related]
16. Basic and clinical aspects of antimuscarinic agents used to treat overactive bladder. Yamada S; Ito Y; Nishijima S; Kadekawa K; Sugaya K Pharmacol Ther; 2018 Sep; 189():130-148. PubMed ID: 29709423 [TBL] [Abstract][Full Text] [Related]
17. Effect of anticholinergic use for the treatment of overactive bladder on cognitive function in postmenopausal women. Geller EJ; Crane AK; Wells EC; Robinson BL; Jannelli ML; Khandelwal CM; Connolly A; Parnell BA; Matthews CA; Dumond JB; Busby-Whitehead J Clin Drug Investig; 2012 Oct; 32(10):697-705. PubMed ID: 22873491 [TBL] [Abstract][Full Text] [Related]
19. Oxybutynin-associated Cognitive Impairment: Evidence and Implications for Overactive Bladder Treatment. Chancellor MB; Lucioni A; Staskin D Urology; 2024 Apr; 186():123-129. PubMed ID: 38296001 [TBL] [Abstract][Full Text] [Related]
20. Rationale for the use of anticholinergic agents in overactive bladder with regard to central nervous system and cardiovascular system side effects. Cetinel B; Onal B Korean J Urol; 2013 Dec; 54(12):806-15. PubMed ID: 24363860 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]